C
리센스메디컬
394420KOSDAQ의료용 기기 제조업53.5 / 100
Reference Date: 2026-04-13
Financial Score16.0 / 40
News Sentiment12.5 / 25
Momentum15.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk. Surged 19.8% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
License Medical develops innovative medical devices through the FDA De Novo process and specializes in regulatory evaluation for retinal and diagnostic medical devices. The company leverages cryogenic cooling technology and transdermal drug delivery systems to create advanced solutions for ophthalmic conditions such as macular degeneration and diabetic retinopathy.
Number of Employees
55people
Average Salary
54.0M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 26.524.0Point
PBR
—Industry Average 1.703.5Point
ROE
—Industry Average 8.003.5Point
Debt Ratio
27.41Industry Average 10.950.0Point
2.5x industry avg (risky)
Trend 5.0 / 10 points
Revenue Growth Rate
1.5 / 3
Operating Profit Growth Rate
1.5 / 3
ROE Trend
2.0 / 4
Detailed News Sentiment
6 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50
- Neutral
Detailed Momentum
52-week position6.0Point
52w upper range (63%)
Current 22,100Won52-week high 24,20052-week low 18,450
1-month return6.0Point
1m +19.78% (strong rise)
Volume trend3.0Point
Volume dry-up
Detailed Disclosure
11 totalPositive 0Neutral 11Negative 0
- Neutral주식등의대량보유상황보고서(일반)2026-04-07
- Neutral주식등의대량보유상황보고서(약식)2026-04-07
- Neutral주식등의대량보유상황보고서(약식)2026-04-07
- Neutral주식등의대량보유상황보고서(약식)2026-04-07
- Neutral[기재정정]주식등의대량보유상황보고서(약식)2026-04-07